Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Krishna Institute of Medical Sciences EV-to-EBITDA?
Krishna Institute of Medical SciencesNSE:KIMS +0.38%88 EV-to-EBITDA is 40.51 as of Sep. 02, 2026, which is 62% above its 10-year median of 25.08. GuruFocus rates NSE:KIMS with a GF Score™ of 88/100 and a GF Value™ of ₹870.10 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 515 Healthcare Providers & Services companies, Krishna Institute of Medical Sciences ranks worse than 91.07% on this metric.
NSE:KIMS'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 16.24 Med: 25.08 Max: 44.85
Current: 40.5
During the past 8 years, the highest EV-to-EBITDA of Krishna Institute of Medical Sciences was 44.85. The lowest was 16.24. And the median was 25.08.
NSE:KIMS's EV-to-EBITDA is ranked worse than 91.07% of 515
companies
in the Healthcare Providers & Services industry
Industry Median: 10.43
vs NSE:KIMS: 40.50
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Krishna Institute of Medical Sciences (NSE:KIMS) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Krishna Institute of Medical Sciences's PE Ratio (TTM) for today is calculated as:
Krishna Institute of Medical Sciences's share price for today is ₹758.40.
Krishna Institute of Medical Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹5.100.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Krishna Institute of Medical Sciences EV-to-EBITDA Chart
NSE:KIMS vs HCA, THC, EHC: EV-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Krishna Institute of Medical Sciences's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Krishna Institute of Medical Sciences EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Krishna Institute of Medical Sciences's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Krishna Institute of Medical Sciences's EV-to-EBITDA falls into.
Krishna Institute of Medical Sciences's current Enterprise Value is ₹348,640 Mil.
Krishna Institute of Medical Sciences's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹8,607 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Krishna Institute of Medical Sciences (NSE:KIMS) has a EV-to-EBITDA of 40.51 as of Sep. 02, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Krishna Institute of Medical Sciences. This is 62% above median its historical median of 25.08. Over the past decade, Krishna Institute of Medical Sciences' EV-to-EBITDA has ranged from 16.24 to 44.85. According to the industry distribution chart, Krishna Institute of Medical Sciences ranks #469 out of 515 companies in the Healthcare Providers & Services industry, placing it in the top 91.1%.
Is Krishna Institute of Medical Sciences' EV-to-EBITDA too high?
Krishna Institute of Medical Sciences' current EV-to-EBITDA of 40.51 is 62% above median its 10-year median of 25.08. Over the past 10 years, this metric has ranged from a low of 16.24 to a high of 44.85. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.43. Krishna Institute of Medical Sciences' value of 40.51 is 288.4% above this industry median. Based on the distribution chart, Krishna Institute of Medical Sciences ranks #469 out of 515 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Krishna Institute of Medical Sciences has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Krishna Institute of Medical Sciences' EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Krishna Institute of Medical Sciences ranks #469 out of 515 companies for EV-to-EBITDA. This places Krishna Institute of Medical Sciences in the lower half of its industry. The industry median EV-to-EBITDA is 10.43. Krishna Institute of Medical Sciences' value of 40.51 is 288.4% above this benchmark. Historically, Krishna Institute of Medical Sciences' own EV-to-EBITDA has ranged from 16.24 to 44.85 over the past decade. While the company's 10-year median is 25.08 vs. the industry median of 10.43, Krishna Institute of Medical Sciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.43, based on 515 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Krishna Institute of Medical Sciences's current EV-to-EBITDA of 40.51 is 288.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Krishna Institute of Medical Sciences. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Krishna Institute of Medical Sciences's current EV-to-EBITDA is 40.51, which is 62% above median its own 10-year median of 25.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krishna Institute of Medical Sciences stock overvalued right now?
Based on GuruFocus' analysis, Krishna Institute of Medical Sciences (NSE:KIMS) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹870.10, compared to a current price of ₹758.40 — trading 12.8% below its estimated fair value. The current EV-to-EBITDA is 40.51, which is 62% above median its 10-year median of 25.08 and 288.4% above the Healthcare Providers & Services industry median of 10.43. Krishna Institute of Medical Sciences' overall GF Score™ is 88/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Krishna Institute of Medical Sciences (NSE:KIMS), the current EV-to-EBITDA is 40.51 as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Krishna Institute of Medical Sciences (NSE:KIMS) Overvalued in 2026?
Based on GuruFocus' analysis, Krishna Institute of Medical Sciences stock appears to be undervalued.
The current stock price of ₹758.40 is trading 12.8% below its estimated GF Value™ of ₹870.10.
GuruFocus considers Krishna Institute of Medical Sciences to be Modestly Undervalued.
Key valuation signals for NSE:KIMS:
EV-to-EBITDA: 40.51 (62% above median its 10-year median of 25.08)
GF Value™: ₹870.10 vs. price of ₹758.40 (12.8% below fair value)
Industry Position: 288.4% above the Healthcare Providers & Services median (#469 of 515)
No single metric tells the full story. See the NSE:KIMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Krishna Institute of Medical Sciences Ltd is a healthcare group in Secunderabad and Telangana. It offers a comprehensive range of healthcare services, including oncology, cardiac sciences, neurosciences, gastric sciences, orthopedics, renal sciences, organ transplantation, mother and child care, and many more. The firm generates key revenue from Hospital services and Pharmacy.
88GF Score
Get the complete analysis for NSE:KIMS
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:KIMS has been successfully added to your 
